AEGON ASSET MANAGEMENT UK Plc Lowers Stake in Relx Plc $RELX

Key Points

• AEGON ASSET MANAGEMENT UK Plc has reduced its holdings in Relx Plc by 3.5%, now owning 270,920 shares valued at approximately $14.7 million.
• Several large investors have recently increased their stakes in Relx, with Larson Financial Group increasing its position by 612.5% in the first quarter.
• Analysts are mixed on Relx’s stock, with ratings ranging from a "strong-buy" to "hold," and an overall average rating of "Buy".

AEGON ASSET MANAGEMENT UK Plc reduced its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 3.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 270,920 shares of the technology company's stock after selling 9,969 shares during the period. AEGON ASSET MANAGEMENT UK Plc's holdings in Relx were worth $14,716,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Larson Financial Group LLC lifted its position in Relx by 612.5% during the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company's stock valued at $26,000 after acquiring an additional 441 shares during the period. WPG Advisers LLC purchased a new position in Relx during the 1st quarter valued at about $28,000. Golden State Wealth Management LLC lifted its position in Relx by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock valued at $30,000 after acquiring an additional 294 shares during the period. Cornerstone Planning Group LLC lifted its position in Relx by 325.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company's stock valued at $37,000 after acquiring an additional 530 shares during the period. Finally, Ameritas Advisory Services LLC bought a new stake in Relx during the 2nd quarter valued at about $64,000. 15.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

RELX has been the subject of a number of analyst reports. Wall Street Zen lowered shares of Relx from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Morgan Stanley restated an "overweight" rating on shares of Relx in a research note on Thursday, September 11th. Weiss Ratings restated a "buy (b)" rating on shares of Relx in a research note on Wednesday, October 8th. Barclays restated an "overweight" rating on shares of Relx in a research note on Tuesday, October 7th. Finally, Kepler Capital Markets upgraded shares of Relx from a "hold" rating to a "strong-buy" rating in a research note on Thursday, September 18th. One analyst has rated the stock with a Strong Buy rating and five have assigned a Buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy".

Relx Stock Performance

Shares of RELX stock opened at $45.49 on Wednesday. The company has a 50 day moving average price of $46.99 and a 200-day moving average price of $50.74. Relx Plc has a 52 week low of $44.19 and a 52 week high of $56.33. The firm has a market capitalization of $83.12 billion, a PE ratio of 24.45, a P/E/G ratio of 2.94 and a beta of 0.87. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55.

Relx Cuts Dividend

The business also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were paid a $0.2634 dividend. The ex-dividend date was Friday, August 8th. This represents a dividend yield of 170.0%. Relx's payout ratio is currently 28.49%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.